XML 83 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net income $ 877,087 $ 298,814
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 146,284 189,961
Amortization of operating lease right-of-use assets 95,566  
Loss on impairment of assets 25,470 10,030
Gain on sales of subsidiaries and disposal of property and equipment, net (814,202) (292,999)
Gain on derivative instruments (8,260) (92,749)
(Payments for) proceeds from settlement of derivative contracts (8,233) 14,117
Loss on debt extinguishment 26,901 7,481
Non-cash interest expense 3,386 14,651
Non-cash share-based compensation expense 9,581 10,492
Bad debt expense 80,957 83,029
Deferred income taxes (3,107) (389)
Unrealized foreign currency exchange loss 8,434 53,731
Non-cash loss (gain) from non-income tax contingencies 5,196 (843)
Other, net (6,849) (11,607)
Changes in operating assets and liabilities:    
Receivables (273,830) (288,747)
Prepaid expenses and other assets (56,726) (50,919)
Accounts payable and accrued expenses (14,102) (6,263)
Income tax receivable/payable, net (39,734) (10,084)
Deferred revenue and other liabilities 258,449 428,664
Net cash provided by operating activities 312,268 356,370
Cash flows from investing activities    
Purchase of property and equipment (102,147) (150,458)
Expenditures for deferred costs (12,086) (13,182)
Receipts from sales of discontinued operations, net of cash sold, property and equipment and other 1,141,695 375,792
Settlement of derivatives related to sale of discontinued operations and net investment hedge 12,866 (9,960)
Proceeds from corporate-owned life insurance and property insurance recoveries 0 24,641
Business acquisitions, net of cash acquired (1,205) 0
Payments from (to) related parties 84 (8)
Proceeds from sale of investment 11,473 0
Net cash provided by investing activities 1,050,680 226,825
Cash flows from financing activities    
Proceeds from issuance of long-term debt, net of original issue discount 724,074 383,594
Payments on long-term debt (2,189,779) (838,542)
Payments of deferred purchase price for acquisitions (19,787) (17,588)
Payments to purchase noncontrolling interests (5,761) (127)
Payment of dividends on Series A Preferred Stock 0 (11,103)
Proceeds from exercise of stock options 1,714 0
Payments to repurchase common stock (87,921) 0
Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options (1,509) (1,744)
Payments of debt issuance costs (6,557) (490)
Payments to purchase noncontrolling interests (2,032) (912)
Net cash used in financing activities (1,587,558) (486,912)
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash (8,808) (4,534)
Change in cash included in current assets held for sale 157,595 (41,233)
Net change in Cash and cash equivalents and Restricted cash (75,823) 50,516
Cash and cash equivalents and Restricted cash at beginning of period 583,572 525,745
Cash and cash equivalents and Restricted cash at end of period $ 507,749 $ 576,261